Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTU vs Methimazole in Graves' Disease: Effects on Atherosclerosis Markers
NCT05118542Phase 3Completed
- Sponsor
- Universitas Indonesia
- Start
- Jan 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in Graves' disease comparing PTU Group with Methimazole Group (2 arms). Primary endpoints: Pulse Wave Velocity at 3 months and Carotid Intima-Media Thickness at 3 months. Started Jan 2019; status: completed.
02
Drugs
propylthiouracilmethimazole
03
Conditions
Graves' disease
Beyond the preview
Go deeper on NCT05118542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05118542.